RATIONALE: Interferon gamma (IFN-γ) release assays for latent tuberculosis infection result in a larger-than-expected number of conversions and reversions in occupational screening programs, and reproducibility of test results is a concern. OBJECTIVES: Knowledge of the relative contribution and extent of the individual sources of variability (immunological, preanalytical, or analytical) could help optimize testing protocols. METHODS: We performed a systematic review of studies published by October 2013 on all potential sources of variability of commercial IFN-γ release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB). The included studies assessed test variability under identical conditions and under different conditions (the latter both overall and stratified by individual sources of variability). Linear mixed effects models were used to estimate within-subject SD. MEASUREMENTS AND MAIN RESULTS: We identified a total of 26 articles, including 7 studies analyzing variability under the same conditions, 10 studies analyzing variability with repeat testing over time under different conditions, and 19 studies reporting individual sources of variability. Most data were on QuantiFERON (only three studies on T-SPOT.TB). A considerable number of conversions and reversions were seen around the manufacturer-recommended cut-point. The estimated range of variability of IFN-γ response in QuantiFERON under identical conditions was ±0.47 IU/ml (coefficient of variation, 13%) and ±0.26 IU/ml (30%) for individuals with an initial IFN-γ response in the borderline range (0.25-0.80 IU/ml). The estimated range of variability in noncontrolled settings was substantially larger (±1.4 IU/ml; 60%). Blood volume inoculated into QuantiFERON tubes and preanalytic delay were identified as key sources of variability. CONCLUSIONS: This systematic review shows substantial variability with repeat IFN-γ release assays testing even under identical conditions, suggesting that reversions and conversions around the existing cut-point should be interpreted with caution.
RATIONALE: Interferon gamma (IFN-γ) release assays for latent tuberculosis infection result in a larger-than-expected number of conversions and reversions in occupational screening programs, and reproducibility of test results is a concern. OBJECTIVES: Knowledge of the relative contribution and extent of the individual sources of variability (immunological, preanalytical, or analytical) could help optimize testing protocols. METHODS: We performed a systematic review of studies published by October 2013 on all potential sources of variability of commercial IFN-γ release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB). The included studies assessed test variability under identical conditions and under different conditions (the latter both overall and stratified by individual sources of variability). Linear mixed effects models were used to estimate within-subject SD. MEASUREMENTS AND MAIN RESULTS: We identified a total of 26 articles, including 7 studies analyzing variability under the same conditions, 10 studies analyzing variability with repeat testing over time under different conditions, and 19 studies reporting individual sources of variability. Most data were on QuantiFERON (only three studies on T-SPOT.TB). A considerable number of conversions and reversions were seen around the manufacturer-recommended cut-point. The estimated range of variability of IFN-γ response in QuantiFERON under identical conditions was ±0.47 IU/ml (coefficient of variation, 13%) and ±0.26 IU/ml (30%) for individuals with an initial IFN-γ response in the borderline range (0.25-0.80 IU/ml). The estimated range of variability in noncontrolled settings was substantially larger (±1.4 IU/ml; 60%). Blood volume inoculated into QuantiFERON tubes and preanalytic delay were identified as key sources of variability. CONCLUSIONS: This systematic review shows substantial variability with repeat IFN-γ release assays testing even under identical conditions, suggesting that reversions and conversions around the existing cut-point should be interpreted with caution.
Authors: Sharon E McMullen; David A Pegues; Frances S Shofer; Alexandra C Sheller; Evelyn B Wiener Journal: Clin Infect Dis Date: 2014-02-27 Impact factor: 9.079
Authors: Mariska M G Leeflang; Jonathan J Deeks; Constantine Gatsonis; Patrick M M Bossuyt Journal: Ann Intern Med Date: 2008-12-16 Impact factor: 25.391
Authors: William C Whitworth; Lanette R Hamilton; Donald J Goodwin; Carlos Barrera; Kevin B West; Laura Racster; Laura J Daniels; Stella O Chuke; Brandon H Campbell; Jamaria Bohanon; Atheer T Jaffar; Wanzer Drane; David Maserang; Gerald H Mazurek Journal: PLoS One Date: 2012-09-06 Impact factor: 3.240
Authors: Richard D Powell; William C Whitworth; John Bernardo; Patrick K Moonan; Gerald H Mazurek Journal: PLoS One Date: 2011-06-08 Impact factor: 3.240
Authors: William C Whitworth; Donald J Goodwin; Laura Racster; Kevin B West; Stella O Chuke; Laura J Daniels; Brandon H Campbell; Jamaria Bohanon; Atheer T Jaffar; Wanzer Drane; Paul A Sjoberg; Gerald H Mazurek Journal: PLoS One Date: 2014-01-23 Impact factor: 3.240
Authors: Elisa Nemes; Virginie Rozot; Hennie Geldenhuys; Nicole Bilek; Simbarashe Mabwe; Deborah Abrahams; Lebohang Makhethe; Mzwandile Erasmus; Alana Keyser; Asma Toefy; Yolundi Cloete; Frances Ratangee; Thomas Blauenfeldt; Morten Ruhwald; Gerhard Walzl; Bronwyn Smith; Andre G Loxton; Willem A Hanekom; Jason R Andrews; Maria D Lempicki; Ruth Ellis; Ann M Ginsberg; Mark Hatherill; Thomas J Scriba Journal: Am J Respir Crit Care Med Date: 2017-09-01 Impact factor: 21.405
Authors: Thara K Venkatappa; Rose Punnoose; Dolly J Katz; Michael P Higgins; Niaz Banaei; Edward A Graviss; Robert W Belknap; Christine S Ho Journal: J Clin Microbiol Date: 2019-10-23 Impact factor: 5.948
Authors: Paul K Drain; Kristina L Bajema; David Dowdy; Keertan Dheda; Kogieleum Naidoo; Samuel G Schumacher; Shuyi Ma; Erin Meermeier; David M Lewinsohn; David R Sherman Journal: Clin Microbiol Rev Date: 2018-07-18 Impact factor: 26.132
Authors: Rishi K Gupta; Marc Lipman; Charlotte Jackson; Alice J Sitch; Jo Southern; Francis Drobniewski; Jonathan J Deeks; Chuen-Yan Tsou; Chris Griffiths; Jennifer Davidson; Colin Campbell; Oliver Stirrup; Mahdad Noursadeghi; Heinke Kunst; Pranab Haldar; Ajit Lalvani; Ibrahim Abubakar Journal: Am J Respir Crit Care Med Date: 2020-04-15 Impact factor: 21.405
Authors: Camilla H Drabe; Lasse S Vestergaard; Marie Helleberg; Nyagonde Nyagonde; Michala V Rose; Filbert Francis; Ola P Theilgaard; Jens Asbjørn; Ben Amos; Ib Christian Bygbjerg; Morten Ruhwald; Pernille Ravn Journal: Am J Trop Med Hyg Date: 2016-02-01 Impact factor: 2.345